Almac Group
Almac is a pharmaceutical service provider with over 30 years experience. The company provides a range of services including research and development, pharmaceutical testing and clinical trials as well as the commercialisation of pharmaceutical products. The company has experience in biomarker discovery and development through its partners and through internal R&D.
Almac provides comprehensive support from drug discovery through to scale-up and launch of new drugs. Pharmaceutical development includes pre-formulation of drugs, testing and taking them to market. The company has three chemical trial sites globally, with one in Northern Ireland situated at Craigavon.
The company also specialises in the design and manufacture of drug packaging including blistering, bottling and walleting/carding of pharmaceuticals.
Financial Data
-
30th Sep 19 Source: CRO
- €742.8 million turnover
-
€55.8 million
profit - 5,150 employees
-
30th Sep 18 Source: CRO
- €619.3 million turnover
-
€31.2 million
profit - 4,978 employees
- 11 more years available »
Ranking
By Turnover
(€742.8 million)- 123rd in Top Companies
- 19th in Health
By Employees
(5,150)- 43rd in Top Companies
- 6th in Health
-
- 5,150
- €742.8 million
Employees
- Alan Armstrong CEO/Managing Director
Latest News
- 9:03pm US owner of Boots explores possible sale of pharmacy retail chain
- 6:54pm European shares shed early gains as US jobs numbers disappoint
- 5:40pm Yew Grove investor Quanta backs off making rival bid
- 5:30pm Liquidator wants Alan Hynes to be personally liable for €4.8m
- 5:04pm Bus companies in talks with State over extending pandemic supports